SN

Sahiba Nasrin

Active Director Director DIN 10408606
DIN 10408606 First appointment Nov 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Sahiba Nasrin

Data last updated:

Sahiba Nasrin is a Director at Medaplus Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Medaplus Pharmaceuticals Private Limited reported revenue of ₹8 Lakh (FY 2025).

DIN 10408606
Primary Designation Director
Industry Pharma
First Appointment 29 Nov 2023
Oldest Company Age 2 yrs
Largest company Medaplus Pharmaceuticals Private Limited · ₹8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Nov 20232023₹8 Lakh (FY 2025)Active

Board colleagues of Sahiba Nasrin

NameDINCompanyDesignation
Sadiq Hussain10408607Medaplus Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medaplus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sahiba Nasrin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sahiba Nasrin

Sahiba Nasrin currently holds 1 directorship: Medaplus Pharmaceuticals Private Limited (Director, since 29 Nov 2023, revenue ₹8 Lakh (FY 2025)).

Sahiba Nasrin was first appointed on 29 Nov 2023 as Director at Medaplus Pharmaceuticals Private Limited.

The current boards of Sahiba Nasrin's companies include Sadiq Hussain (Medaplus Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available